Package size

100 Tests, 50 Tests, 25 Tests, 10 Tests, 5 Tests, 100 Tests (N-QC), 50 Tests (N-QC), 25 Tests (N-QC), 10 Tests (N-QC), 5 Tests (N-QC).

Intended use

This device is intended to be used for the in vitro quantitative determination of Progesterone in human whole blood, serum or plasma. And it is for professional use only, not for self-testing of untrained individuals, nor for near-patient testing.

Summary

Progesterone is a steroid hormone with a molecular weight of 314.5D. It is mainly formed in the cells of the corpus luteum and the placenta during pregnancy. The concentration of progesterone is closely related to the growth and degeneration of the corpus luteum. It is almost undetectable during the follicular phase of the menstrual cycle, while the day before ovulation, the concentration of progesterone increases. During the luteal phase, the synthesis of progesterone increases, while pregnediol, the major degradation product of progesterone, is excreted in the urine during the second half of the menstrual cycle. Progesterone is able to cause the uterine mucosa to transform into gland-rich tissue (secretory phase). Progesterone assays for reproductive diagnosis: detection of ovulation and estimation of the luteal phase. Current clinical methods for detecting Progesterone include chemiluminescence method, immunochromatography method, and etc.

PRODUCT PARAMETER

TEST PARAMETER
Method	Microfluidic Fluorescent Immunoassay	Test	LYOFIA® Progesterone
Format	Cassette	Reaction Time	10min
Linearity	1～120nmol/L	Reference Interval	IFU
Sample	WB / S / P	Certificate	CE

ORDERING
Cat. No.	LMTHPG25	Applicable analyzer	LYOFIA-I, LYOFIA 8,	Kit Size	25T
Cat. No.	LATHPG25	Applicable analyzer	LYOFIA 100 (Full-Automatic)	Kit Size	25T